Glickman Mark A
Co-Chief Executive Officer at TXMD; Chief Commercial Officer at Aralez Pharmaceuticals Inc.; EVP - Sales and Marketing at AUXILIUM PHARMACEUTICALS INC
- Sold, on record
- $1.6M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Dec 6, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- TXMDTherapeuticsMD, Inc.Co-Chief Executive Officer
- Aralez Pharmaceuticals Inc.Chief Commercial Officer
- AUXILIUM PHARMACEUTICALS INCEVP - Sales and Marketing
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- AUXILIUM PHARMACEUTICALS INC47,952 shares
- Aralez Pharmaceuticals Inc.5,725 shares
- TXMD440 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AUXILIUM PHARMACEUTICALS INCUnusualNov 20, 2014 2014
Sold 47,952 shares at $33.16 ($1.6M)
Glickman Mark A, EVP - Sales and Marketing
Sold 63.2% of holdings ($2.5M position)27,911 shares leftFirst sale on recordFiling
- 2 Form 4 sale Aralez Pharmaceuticals Inc.Plan not statedMar 19, 2018 +1215 days
Sold 5,725 shares at $1.70 ($10k)
Glickman Mark A, Chief Commercial Officer
Sold 2.2% of holdings ($435k position)250,188 shares leftFirst sale on recordFiling
- 3 Form 4 sale TXMDUnusualDec 6, 2022 +1723 days
Sold 440 shares at $4.92 ($2k)
Glickman Mark A, Co-Chief Executive Officer
Sold 25.4% of holdings ($9k position)1,294 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | Dec 9, 2022 | TXMD | Co-Chief Executive Officer | Form 4 sale | 440 | $2k | 25.4% | Unusual | SEC |
| Mar 19, 2018 | Mar 21, 2018 | Aralez Pharmaceuticals Inc. | Chief Commercial Officer | Form 4 sale | 5,725 | $10k | 2.2% | Plan not stated | SEC |
| Nov 20, 2014 | Nov 24, 2014 | AUXILIUM PHARMACEUTICALS INC | EVP - Sales and Marketing | Form 4 sale | 47,952 | $1.6M | 63.2% | Unusual | SEC |